Extending the in vivo half-life of a novel engineered mammalian asparaginase via its binding to human serum albumin
Ended Project Grant Awarded Last action
- Award ID
- R43CA232798
- Recipient
-
Enzyme By Design Inc. UEI CKUTZNUHGRN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $399,999
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Chicago, IL 60612, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $399,999 |
Quick answers
Who received award R43CA232798?
R43CA232798 was awarded to Enzyme By Design Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2020.
How much is award R43CA232798 worth?
$399,999 has been obligated on R43CA232798.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award